|
|
News and Downloads
Press Releases
|
June 1, 2009 - Orlando, Fla. - Source MDx validates molecular diagnostic test to improve the diagnosis of prostate cancer as compared with PSA testing alone, showing the potential to reduce need for biopsies. |
|
|
|
February 27, 2009 - Orlando, Fla. - Dana-Farber Oncologists present results of Source MDx's RNA transcript-based six-gene test to predict survival of castration-resistant prostate cancer patients at GU ASCO Symposium. |
|
|
|
November 3, 2008 - Boulder, Colo. - Source MDx Announces Partnership with Brigham and Women’s Hospital To Study RNA-Based Biomarkers for Multiple Sclerosis. |
|
|
|
December 28, 2007 - BioWorld Today - Source MDx Signs Pfizer To
RNA-Based Biomarker Deal. |
|
|
|
December 27, 2007 - Source MDx Announces Translational Molecular Medicine Collaboration with Pfizer. |
Patents
|
|
Precision & Calibration Patent, US6692916 - Issued 02.17.04, Systems and Methods for Characterizing a Biological Condition or Agent Using Precision Gene Expression Profiles |
|
|
|
Normals Patent, US6960439 - Issued 11.1.05, Identification, Monitoring & Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles |
|
|
|
Indicies Patent, US6964850 - Issued 11.15.06, Identification, Monitoring & Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles |
Science Papers
Posters
|
|
Whole-blood RNA Transcript-Based Prognostic Model for Predicting Survival in Men with Castration-Resistant Prostate Cancer (CRPC) |
|
|
|
Inhibition of Proinflammatory Gene Expression by Soluble TNF Receptors in Human Whole Blood Cultures: Marked Contrast Between TNF p55 Receptor (PEG sTNF-RI) and TNF p75 Receptor (ETANERCEPT) |
|
|
|
Stabilization of Gene Expression Profiles in Post-Phlebotomy Whole Blood Using the *PAXgene® Blood RNA System |
|
|
|
Anti-Tumor Necrosis Factor-α Therapy in a Defined Subpopulation of Rheumatoid Arthritis Patients Reduces Inflammatory Gene Expression in Whole Blood in Comparison to Standard DMARD Therapy Alone |
|
|
|
High-Precision Gene Expression Analysis of Rheumatoid Arthritis (RA) & other Inflammatory Diseases |
Other
|
|
Technical Validation of RNA-Based Biomarkers for Drug Development and Companion Diagnostics |
|
|
|
Source MDx OncoProfiling℠ Biomarker Services for Targeted Oncology Drug Development |
|
